Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
220 participants
OBSERVATIONAL
2007-06-30
2012-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
PRAGUE-25 Trial. Catheter Ablation vs. AADs and Risk Factor Modification.
NCT04011800
Evaluation of the Cardioblate CryoFlex Surgical Ablation System in Longstanding Persistent Atrial Fibrillation
NCT01558635
Prophylactic Maze to Prevent Atrial Fibrillation in Adult Cardiac Surgery
NCT03604432
The Effect of Pulsed-field and Radiofrequency Ablation on Platelet, Coagulation and Inflammation
NCT05603637
Left Atrial Appendage Closure vs. Novel Anticoagulation Agents in Atrial Fibrillation
NCT02426944
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A = MAZE
Patients indicated to a cardiac surgery (bypass, valve repair or combinated surgery)with documented atrial fibrillation in 6 preoperative months undergo the operation together with MAZE procedure
Cox-MAZE III
Maze procedure according to standards of the department
B = non-MAZE
Patients indicated to a cardiac surgery (bypass, valve repair or combinated surgery)with documented atrial fibrillation in 6 preoperative months undergo the operation (without MAZE procedure).
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cox-MAZE III
Maze procedure according to standards of the department
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* atrial fibrillation (paroxysmal, persistent or permanent) present or documented in last 6 month before the operation
* signed informed consent
Exclusion Criteria
* emergent surgery
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charles University, Czech Republic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kralovske Vinohrady University Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zbynek Straka, Prof.,MUDr.,CSc.
Role: PRINCIPAL_INVESTIGATOR
Charles University, Prague
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cardiosurgery Department of University Hospital in Pilsen
Pilsen, , Czechia
Cardiocentre of Kralovske Vinohrady University Hospital
Prague, , Czechia
Cardiology department of Masarykova Hospital Usti nad Labem
Ústí nad Labem, , Czechia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
121402
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.